about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesLiver immunology and its role in inflammation and homeostasisRethinking the immune properties of bilirubin in viral hepatitis: from bench to bedsideNatural killer cells in hepatitis C: Current progressStatus of hepatitis C virus vaccination: Recent updateNK cell function and receptor diversity in the context of HCV infectionInterferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV InfectionImmune-mediated Liver Injury in Hepatitis B Virus InfectionMolecular cancer prevention: Current status and future directionsT cell responses in hepatitis C virus infection: historical overview and goals for future researchRecognition of human oncogenic viruses by host pattern-recognition receptorsHepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlHepatitis C virus infection.Characterization of nonprimate hepacivirus and construction of a functional molecular cloneInterplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.Protective immunity against hepatitis C: many shades of gray.The Strange, Expanding World of Animal Hepaciviruses.Autophagy in HCV infection: keeping fat and inflammation at bayContradictory immune response in post liver transplantation hepatitis B and C.Innate immune cell networking in hepatitis C virus infectionThe Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Natural Killer Cells in Viral Hepatitis.Early virus-host interactions dictate the course of a persistent infectionMathematical modeling provides kinetic details of the human immune response to vaccination.Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus.Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNAInterferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus.Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative DamageEmerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infectionVirus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral controlBystander hyperactivation of preimmune CD8+ T cells in chronic HCV patientsFunctional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production.Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury.Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection
P2860
Q21131160-939113FF-B956-423B-B8B1-46E7E362C3F1Q26750478-E0A02B7A-B3A6-4F4C-B78E-44123F4598C6Q26771481-A091F9D3-DC86-403D-8432-80CA1EAA8DC9Q26773264-A7A3FC7A-5C74-4C46-A52B-8D676B070C51Q26774612-94AF6CD0-FDFF-4B73-AB5A-DC2C62B45575Q26781537-20652343-3D95-42B3-80B0-B2CB4B53FD0DQ26784252-57753C4E-B7A8-4412-83BC-DE121DDF0667Q26786772-466C19B3-D1B5-4F7A-A812-C1F32F5724DCQ26797207-6359B7BF-C8D4-46E3-AE78-C38FDA063FDAQ27003510-151AE86E-5C57-46DB-8965-880D4B02EC68Q27010116-AD043533-6B1C-4193-94D1-12D0AB00250BQ28082128-E062ADB1-56C4-4961-B355-7254C6C36D80Q30235491-7CA9ABF5-4947-43B9-943D-436054B1A55CQ30622630-81B8B499-D397-4A9C-8A32-95EC1DE841B3Q30854409-E3C02411-138F-4224-BD90-7107F50AD614Q33718778-79119765-1E04-47DE-9D8E-4F3FFF4C73D5Q33759224-7F26F508-652A-4114-B48C-EDB7F984ADF4Q33924522-06A902B6-FBA9-4411-BD53-3D700F7E2AC8Q34069393-FFD0B4B0-64DE-474D-ABB5-07347B8773DCQ34152074-5C1C5243-3DA4-477C-97F9-5818008CEEA7Q34341382-EE79D1A5-EE28-429F-91C1-07B23727D49CQ34481429-24DEF274-7E1F-4CA1-B4F3-C17395E14DDDQ34505690-DF171816-450D-4E14-A859-63C811159913Q34876341-2CA79201-BF27-44BF-95A5-94B4D100BA36Q34885695-9D836063-8658-4537-B71A-54921F5A3C08Q35535783-483096E4-6981-49E6-9387-EE7F23E7040BQ35889892-2AF6193D-14B3-4F48-A5B8-9AF6A1B832C7Q35989977-99A18851-9ED4-47BC-9F48-F3A4A43FFB4AQ36050577-20EE3323-AFE0-498C-BFCB-033D7E8D248DQ36056232-D7387CB8-83B5-403D-AA98-C545CA5E3D45Q36073739-1C8A0700-823C-4E96-BAC7-968F96FD34BFQ36280098-CDD25A93-2904-4D81-A0C5-93CC3F2AF2CAQ36295405-26CF65FB-ED49-4927-AF11-9B464DFB93D1Q36315988-6E18BD07-E631-4001-AD3B-FA61A9DEF224Q36460968-9F56E139-9EAD-44E6-BBD6-4306A29A319CQ36501145-586C288E-87AE-423C-A738-94CCA271BD16Q36575593-6935AA94-1651-4399-B970-E968789450EFQ36914497-F2BA2979-2692-49E2-9EB7-1C9D59030BA3Q36980410-A06DE0A4-DBE2-4313-8012-87A002736EC3Q36993610-38EEAC34-568F-47CA-8E78-E533D6E6AA3E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immune responses to HCV and other hepatitis viruses
@ast
Immune responses to HCV and other hepatitis viruses
@en
Immune responses to HCV and other hepatitis viruses
@nl
type
label
Immune responses to HCV and other hepatitis viruses
@ast
Immune responses to HCV and other hepatitis viruses
@en
Immune responses to HCV and other hepatitis viruses
@nl
prefLabel
Immune responses to HCV and other hepatitis viruses
@ast
Immune responses to HCV and other hepatitis viruses
@en
Immune responses to HCV and other hepatitis viruses
@nl
P2860
P3181
P1433
P1476
Immune responses to HCV and other hepatitis viruses
@en
P2093
Su-Hyung Park
P2860
P3181
P356
10.1016/J.IMMUNI.2013.12.010
P407
P577
2014-01-16T00:00:00Z